|
Delayed
OTC Markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | -99.33% |
| 08-06 | Morphic Medical Announces Board Appointments, Effective August 6, 2026 | CI |
| 08-03 | Morphic Medical Inc. Provides Update On Reset System Clinical And Commercial Progress | CI |
| Market Cap | 440K 380K 359K 326K 611K 42.08M 614K 4.27M 1.64M 21.41M 1.65M 1.62M 67.65M | P/E 2019 |
-1.12x | P/E 2020 | -0.03x |
|---|---|---|---|---|---|
| Enterprise Value | 3.28M 2.83M 2.68M 2.43M 4.55M 313M 4.57M 31.78M 12.22M 159M 12.32M 12.05M 504M | EV / Sales 2019 |
-
| EV / Sales 2020 | - |
| Free-Float |
-
| Yield 2019 * |
-
| Yield 2020 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Mike Gutteridge
CEO | Chief Executive Officer | - | 05/08/2025 |
Jane Wright
DFI | Director of Finance/CFO | 57 | 01/08/2025 |
| Chief Tech/Sci/R&D Officer | - | 01/04/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Ginger Glaser
BRD | Director/Board Member | - | 20/10/2020 |
Alex Escalona
BRD | Director/Board Member | - | - |
John R. Barr
BRD | Director/Board Member | 69 | 01/10/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/28/21 A | Free | Chairman | 1,384,483 | 0.4875% | ||
| 1/28/21 A | Free | Chief Executive Officer | 11,075,869 | 3.8998% |
| 2019 | 2020 | |
|---|---|---|
| Net sales | - | - |
| Net income | -17.33M -14.93M -14.14M -12.82M -24.05M -1.66B -24.17M -168M -64.58M -842M -65.1M -63.67M -2.66B | -11.14M -9.59M -9.08M -8.23M -15.45M -1.06B -15.53M -108M -41.49M -541M -41.82M -40.9M -1.71B |
| Net Debt | 2.89M 2.49M 2.36M 2.13M 4.01M 276M 4.03M 27.97M 10.76M 140M 10.84M 10.6M 443M | 2.84M 2.45M 2.32M 2.1M 3.94M 271M 3.96M 27.51M 10.58M 138M 10.66M 10.43M 436M |
Employees
-
Sector
-
- Stock Market
- Stocks
- GIDYL Stock
Select your edition
All financial news and data tailored to specific country editions
















